Roche denied Zydus' trade secrets as Indian court stresses patent burden of proof
Swiss multinational pharmaceutical company F. Hoffmann-La Roche has been unsuccessful in its bid to compel India's Zydus Lifesciences to disclose the manufacturing process of its breast cancer drug, Sigrima. The Delhi...To view the full article, register now.
Already a subscriber? Click here to view full article